Dmitry Vyushkov

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma

Al B. Benson, Zev A. Wainberg, J. Randolph Hecht et al. · The Oncologist · 2017 · 176 citations · Full text

Medicine, Oncology, Pharmacology +14

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic <i>KRAS</i> Mutant Colorectal Adenocarcinoma

J. Randolph Hecht, Al B. Benson, Dmitry Vyushkov et al. · The Oncologist · 2017 · 126 citations · Full text

Medicine, Oncology, Pharmacology +13

A Phase 2 Randomized, Double-Blind, Placebo Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First Line Treatment of Pancreatic Adenocarcinoma

Al B. Benson, Johanna C. Bendell, Zev A. Wainberg et al. · Annals of Oncology · 2014 · 11 citations

Medicine, Oncology, Pharmacology +8